PROP
61

State Prescription Drug Purchases. Pricing Standards. Initiative Statute.

State Prescription Drug Purchases. Pricing Standards. Initiative Statute.

Summary

Prohibits state from buying any prescription drug from a drug manufacturer at price over lowest price paid for the drug by United States Department of Veterans Affairs. Exempts managed care programs funded through Medi-Cal. Fiscal Impact: Potential for state savings of an unknown amount depending on (1) how the measure’s implementation challenges are addressed and (2) the responses of drug manufacturers regarding the provision and pricing of their drugs.

Money Raised

Chart depicts total fundraising by all committees primarily formed for and against Prop 61.Totals are updated daily with contributions from Power Search opens new window and adjustments from the most recent Political Reform Division analysis. opens new window

Largest Contributions

Showing the 10 largest contributions to committees formed primarily for and against Prop 61 in the election cycle when it appeared on the ballot. Contributions in earlier election cycles and contributions between allied committees are excluded. For more information on funding for ballot measure campaigns, visit the Power Search opens new window campaign finance search engine.

Yes on Prop 61

AIDS HEALTHCARE FOUNDATION
06/28/2016
$5,000,000
AIDS HEALTHCARE FOUNDATION
09/20/2016
$5,000,000
AIDS HEALTHCARE FOUNDATION
12/29/2015
$3,000,000
AIDS HEALTHCARE FOUNDATION
10/27/2016
$2,000,000
AIDS HEALTHCARE FOUNDATION
11/02/2016
$1,000,000
AIDS HEALTHCARE FOUNDATION
11/04/2016
$500,000
AIDS HEALTHCARE FOUNDATION
11/07/2016
$500,000
AIDS HEALTHCARE FOUNDATION
10/20/2016
$300,000
CALIFORNIA NURSES ASSOCIATION INITIATIVE POLITICAL ACTION COMMITTEE
11/04/2016
$207,750
AIDS HEALTHCARE FOUNDATION
07/09/2015
$200,000

No on Prop 61

Merck & Co., Inc.
04/01/2016
$5,860,000
Johnson & Johnson
09/29/2015
$5,700,000
Pfizer, Inc.
12/02/2015
$5,700,000
AbbVie Inc.
11/03/2015
$4,150,000
Amgen Inc.
11/03/2015
$4,150,000
AstraZeneca Pharmaceuticals LP
11/24/2015
$4,150,000
sanofi-aventis U.S. LLC
01/29/2016
$4,150,000
Gilead Sciences, Inc.
04/14/2016
$4,000,000
Bristol-Myers Squibb Company
09/22/2015
$2,880,000
Novartis Pharmaceuticals Corporation
11/24/2015
$2,880,000

What your vote means

Yes

A YES vote on this measure means: State agencies would generally be prohibited from paying more for any prescription drug than the lowest price paid by the U.S. Department of Veterans Affairs for the same drug.

No

A NO vote on this measure means: State agencies would continue to be able to negotiate the prices of, and pay for, prescription drugs without reference to the prices paid by the U.S. Department of Veterans Affairs.

More on Proposition 61

For background on Proposition 61, an analysis by the legislative analyst, endorsements for and against the measure, and more...

Arguments

Pro

Prop. 61, The California Drug Price Relief Act, would require all prescription drugs purchased by the State of California to be priced at or below the price paid for the same drug by the U.S. Dept. of Veterans Affairs, which pays by far the lowest price of any federal agency.

Con

Experts say Prop. 61 would: increase prescription prices, reduce patient access to needed medicines, produce more bureaucracy and lawsuits that cost taxpayers millions, and hurt veterans by increasing their prescription costs. Strongly opposed by California Medical Association, California NAACP, California Taxpayers Association, Ovarian Cancer Coalition of Greater California, Veterans of Foreign Wars (VFW), Department of California. www.NoProp61.com

Campaigns

For

Aref Aziz
Yes on Prop. 61, Californians for Lower Drug Prices
22815 Ventura Blvd., #405
Los Angeles, CA 91364
(323) 601-8139
Yes@StopPharmaGreed.com
www.StopPharmaGreed.com

Against

No on Prop. 61—Californians Against the Deceptive Rx Proposition
(888) 279-8108
info@noprop61.com
www.NoProp61.com